Abstract:Background: Contrast induced diabetic nephropathy (CIN) is an important cause of hospital-acquired acute renal failure. Our aim was to observe the effect of protein kinase C beta 2 (PKC beta 2) knockdown on human proximal tubular epithelial cells (HK-2 cells) against meglumine diatrizoate and advanced glycation end products (AGEs)-induced apoptosis and autophagy. Methods: Cell viability was detected using cell counting kit-8 (CCK-8) assay in HK-2 cells after disposal with meglumine diatrizoate and AGEs with or without PKC beta 2 siRNA/inhibitor LY333531. Flow cytometry and western blot were used to test cell apoptosis and the related protein levels in meglumine diatrizoate and AGEs co-treated HK-2 cells with or without PKC beta 2 siRNA/inhibitor LY333531. Autophagy related proteins were detected using western blot. Immunofluorescence staining was used to examine the autophagyspecific protein light chain 3 (LC3), and autophagosome and autolysosome formation was observed under a transmission electron microscopy. Results: CCK-8 assay results showed that meglumine diatrizoate inhibited AGEs-induced HK-2 cell viability. Furthermore, meglumine diatrizoate promoted cell apoptosis and the expression level of caspase3 in AGEs-induced HK-2. Western blot results showed that meglumine diatrizoate elevated the expression levels of PKC beta 2 and p-PKC beta 2 in AGEs-induced HK-2 cells, and up-regulated the expression level of Beclin-1 and the ratio of LC3 II/LC3 I, and down-regulated the expression level of p62 in AGEs-induced HK-2 cells. We found that PKC beta 2 knockdown alleviated meglumine diatrizoate and AGEs-induced HK-2 cell apoptosis and autophagy. Intriguingly, PKC beta 2 inhibitor LY333531 reversed 3-methyladenine (3-MA)-induced autophagy inhibition in meglumine diatrizoate and AGEs-induced HK-2 cells. Conclusions: Our findings reveal that inhibiting PKC beta 2 protects HK- 2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy, which provide a novel therapeutic insight for CIN in diabetic patients.

Protein kinase C delta plays a key role in cellular senescence programs of human normal diploid cells

Regulations of Reversal of Senescence by PKC Isozymes in Response to 12-O-Tetradecanoylphorbol-13-Acetate via Nuclear Translocation of pErk1/2

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

Regulation of Thymidine Kinase Expression during Cellular Senescence

c-Jun N-terminal kinase signaling in cellular senescence

PKIB Inhibits cAMP-dependent Protein Kinase to Modulate Cell Senescence

PPARγ Accelerates Cellular Senescence by Inducing P16ink4α Expression in Human Diploid Fibroblasts

Protein kinase D1 phosphorylates CBX8 to facilitate the disassociation of PRC1 complex from p16 promoter and promotes cell senescence

p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

The Protein Kinase D1-mediated Classical Protein Secretory Pathway Regulates the Ras Oncogene-Induced Senescence Response.

TGF-β Signaling in Cellular Senescence and Aging-Related Pathology

Protein kinase CK2 activates Nrf2 via autophagic degradation of Keap1 and activation of AMPK in human cancer cells

Reduced PKC α Activity Induces Senescent Phenotype in Erythrocytes

Inhibition of protein kinase CK2 facilitates cellular senescence by inhibiting the expression of HO-1 in articular chondrocytes

Phenyl 2-pyridyl ketoxime induces cellular senescence-like alterations via nitric oxide production in human diploid fibroblasts

Loss of PKCtheta-GADD45a axis drives triple-negative breast cancer cells into p53-independent senescence

Sustained activation of NF-κB through constitutively active IKKβ leads to senescence bypass in murine dermal fibroblasts

PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts

Cytosolic malate dehydrogenase regulates senescence in human fibroblasts

Protein Kinase D1 is Essential for Ras-Induced Senescence and Tumor Suppression by Regulating Senescence-Associated Inflammation